New supplement trial aims to fight chemo fatigue in breast cancer patients
NCT ID NCT06137833
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 40 times
Summary
This study tests whether a daily supplement called APPORTAL® can reduce fatigue in breast cancer patients undergoing chemotherapy. The supplement contains a mix of vitamins, minerals, and other nutrients. 92 women will take either the supplement or a placebo for 8 weeks, alongside standard exercise recommendations. Researchers will measure changes in fatigue, muscle strength, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Center U.O. Oncologia Medica ed Ematologia IRCCS Humanitas Research Hospital
RECRUITINGRozzano, MILANO, 20089, Italy
Contact
Contact
-
Dipartimento di Oncologia Azienda Sanitaria Universitaria Integrata di Udine
RECRUITINGUdine, UDINE, 33100, Italy
Contact
Contact
-
U.O. Oncologia 2 Universitaria A.O.U. Pisana
RECRUITINGPisa, PISA, 56126, Italy
Contact
Contact
-
U.O.C. Oncologia medica ASST Spedali Civili di Brescia
RECRUITINGBrescia, BRESCIA, 25123, Italy
Contact
Contact
-
UOSD di Medicina di Precisione e Senologia, Policlinico Universitario A. Gemelli
RECRUITINGRome, ROME, 00168, Italy
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
APPORTAL® (a dietary supplement containing vitamins, minerals, L-arginine, L-carnitine, coenzyme Q10, and other nutrients)
What this could lead to
If it works, this could offer a safe, non-drug way to reduce fatigue and improve quality of life for breast cancer patients during chemotherapy.
What could go wrong
This is a small, early-stage trial (92 people) testing a supplement, not a drug. The placebo effect is common in fatigue studies, and results may not apply to all cancer types or treatments.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.